LNSR
NASDAQ
$5.75
LENSAR Inc (LNSR)
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $8.50 (+47.83%)
Market Cap
$69M
Profit Margin
50.9%
P/E Ratio
2.34
Free Cash Flow Yield
-17.84%
Price Chart
Valuation
Market Cap$69M
P/E2.34
P/S1.21
P/B6.56
Profitability
Total Revenue (TTM)$51M
Gross Profit (TTM)$26M
EBITDA-$13M
Profit Margin50.9%
Operating Margin19.1%
EPS$2.42
Financial Health
Free Cash Flow Yield-17.84%
Growth & Risk
Revenue 5Y CAGR+16.54%
FCF 5Y CAGR-0.29%
Beta (5Y)0.49
Sharpe Ratio-1.24